Cargando…

Hypoxia-Related Signature Is a Prognostic Biomarker of Pancreatic Cancer

BACKGROUND: Hypoxia plays a significant role in the pathogenesis of pancreatic cancer, but the effect of hypoxia-related genes in pancreatic cancer remains to be elucidated. This study aimed to identify hypoxia-related genes related to pancreatic cancer and construct a prognostic signature. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing-jing, Shao, Chao, Yin, Yi-xin, Sun, Qiang, Li, Ya-ni, Zha, Ya-wen, Li, Min-ying, Hu, Bang-li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250441/ https://www.ncbi.nlm.nih.gov/pubmed/35789607 http://dx.doi.org/10.1155/2022/6449997

Ejemplares similares

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
por: Tian, Xiong, et al.
Publicado: (2022)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
por: Ren, Min, et al.
Publicado: (2023)

Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
por: Wen, Ya-Dan, et al.
Publicado: (2021)

Comprehensive analysis of gene regulation network and immune signatures of prognostic biomarker YAP1 in pancreatic cancer
por: Yang, Yuan, et al.
Publicado: (2020)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas
por: Zheng, Yi, et al.
Publicado: (2021)

A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
por: Ren, Peng, et al.
Publicado: (2022)

Identification of immunogenic cell death‑related prognostic signatures in pancreatic cancer
por: Yu, Wenjing, et al.
Publicado: (2023)

Prognostic Modeling of Lung Adenocarcinoma Based on Hypoxia and Ferroptosis-Related Genes
por: Liu, Chang, et al.
Publicado: (2022)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma
por: Chen, Qirui, et al.
Publicado: (2023)

A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients
por: Jiao, Yang, et al.
Publicado: (2023)

Hypoxia-based classification and prognostic signature for clinical management of hepatocellular carcinoma
por: Li, Ke, et al.
Publicado: (2023)

CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma
por: Zhou, Chaoting, et al.
Publicado: (2022)

Involvement of Hepcidin in Cognitive Damage Induced by Chronic Intermittent Hypoxia in Mice
por: Zhao, Ya-Shuo, et al.
Publicado: (2021)

Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer
por: Zhong, Jianxin, et al.
Publicado: (2023)

SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer
por: Li, Hao, et al.
Publicado: (2019)

Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer
por: Yang, Yongmei, et al.
Publicado: (2020)

A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020)

Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour
por: Wei, Zhe-Wei, et al.
Publicado: (2020)

Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma
por: Hu, Jing, et al.
Publicado: (2019)

Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
por: Zhang, Wenshuo, et al.
Publicado: (2022)

Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma
por: Luo, Huan, et al.
Publicado: (2020)

Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
por: Li, Zhengtian, et al.
Publicado: (2021)

The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus‐related hepatocellular carcinoma
por: Chen, Shipeng, et al.
Publicado: (2022)

An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer
por: Lian, Penghu, et al.
Publicado: (2019)

Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021)

Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients
por: Liu, Jun, et al.
Publicado: (2021)

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma
por: Shi, Guodong, et al.
Publicado: (2017)

Prognostic Value of microRNA Signature in Patients with Gastric Cancers
por: Liu, Hai-Ting, et al.
Publicado: (2017)

Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
por: Miao, Yan, et al.
Publicado: (2017)

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
por: Li, Xiushen, et al.
Publicado: (2023)

N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
por: Zhao, Zhiying, et al.
Publicado: (2022)

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer
por: Hu, Yue-Xin, et al.
Publicado: (2019)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
por: Xu, Bang-Hao, et al.
Publicado: (2021)

Hsa_circ_0072309 is a prognostic biomarker and is correlated with immune infiltration in gastric cancer
por: Xu, Bei-Bei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t4su0q3ebrisnogbasqubo9pv1